Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Bioadaptives (BDPT) Profit After Tax (2019 - 2025)

Historic Profit After Tax for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to -$379502.0.

  • Bioadaptives' Profit After Tax fell 90800.02% to -$379502.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 3974.82%. This contributed to the annual value of -$904761.0 for FY2024, which is 2699.01% down from last year.
  • Per Bioadaptives' latest filing, its Profit After Tax stood at -$379502.0 for Q3 2025, which was down 90800.02% from -$157914.0 recorded in Q2 2025.
  • In the past 5 years, Bioadaptives' Profit After Tax registered a high of -$13061.0 during Q3 2023, and its lowest value of -$491903.0 during Q1 2021.
  • Its 5-year average for Profit After Tax is -$226173.5, with a median of -$223837.0 in 2022.
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 9527.33% in 2023, then crashed by 90800.02% in 2025.
  • Over the past 5 years, Bioadaptives' Profit After Tax (Quarter) stood at -$214283.0 in 2021, then soared by 86.8% to -$28277.0 in 2022, then crashed by 848.83% to -$268301.0 in 2023, then tumbled by 40.66% to -$377388.0 in 2024, then fell by 0.56% to -$379502.0 in 2025.
  • Its Profit After Tax was -$379502.0 in Q3 2025, compared to -$157914.0 in Q2 2025 and -$197136.0 in Q1 2025.